Sectors
CCEL
Cryo-Cell International, Inc.
3.54
1 x 3.62
1 x 3.92
bid
ask
+
0.04
1.14%
12:04 PM
timesize
| Ytd | 2.91% | |
| 1y | -33.08% |
3.30
day range
3.87
2.72
52 week range
5.43
| Open | 3.64 | Prev Close | 3.50 | Low | 3.30 | High | 3.87 | Mkt Cap | 28.22M |
| Vol | 15.88K | Avg Vol | 9.07K | EPS | -0.33 | P/E | -10.61 | Forward P/E | 96.63 |
| Beta | 0.49 | Short Ratio | 0.51 | Inst. Own | 11.18% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | 11-15 | Earning | 07-18 | 50-d Avg | 3.51 | 200-d Avg | 3.67 | 1yr Est | 9.00 |
| Income Statement | |||
| Total Revenue | 7.78M | ||
| Revenues (USD) | 7.78M | ||
| Cost of Revenue | 1.68M | ||
| Gross Profit | 6.10M | ||
| Operating Expenses | 4.90M | ||
| Research and Development Expense | 99.78K | ||
| Selling, General and Administrative Expense | 4.62M | ||
| Operating Income | 1.20M | ||
| Interest Expense | 441.92K | ||
| Income Tax Expense | 273.20K | ||
| Net Income | 554.59K | ||
| Net Income Common Stock | 554.59K | ||
| Net Income Common Stock (USD) | 554.59K | ||
| Consolidated Income | 554.59K | ||
| Earnings per Basic Share | 0.07 | ||
| Earnings per Basic Share (USD) | 0.07 | ||
| Earnings per Diluted Share | 0.07 | ||
| Earning Before Interest & Taxes (EBIT) | 1.27M | ||
| Earning Before Interest & Taxes (USD) | 1.27M | ||
| Weighted Average Shares | 8.06M | ||
| Weighted Average Shares Diluted | 8.06M | ||
| Balance Sheet | |||
| Cash and Equivalents | 507.30K | ||
| Cash and Equivalents (USD) | 507.30K | ||
| Investments | 2.65M | ||
| Investments Current | 2.65M | ||
| Trade and Non-Trade Receivables | 6.91M | ||
| Current Assets | 11.30M | ||
| Property, Plant & Equipment Net | 21.29M | ||
| Total Assets | 60.71M | ||
| Debt Current | 617.02K | ||
| Total Debt | 8.96M | ||
| Current Liabilities | 15.93M | ||
| Debt Non-Current | 8.34M | ||
| Total Liabilities | 78.46M | ||
| Accumulated Retained Earnings (Deficit) | -37.84M | ||
| Shareholders Equity | -17.76M | ||
| Shareholders Equity (USD) | -17.76M | ||
| Assets Non-Current | 49.40M | ||
| Total Debt (USD) | 8.96M | ||
| Deferred Revenue | 62.77M | ||
| Goodwill and Intangible Assets | 2.78M | ||
| Inventory | 1.07M | ||
| Liabilities Non-Current | 62.53M | ||
| Trade and Non-Trade Payables | 2.85M | ||
| Tax Assets | 23.62M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 343.53K | ||
| Net Cash Flow from Financing | -1.62M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 257.63K | ||
| Capital Expenditure | -32.70K | ||
| Issuance (Purchase) of Equity Shares | 23.25K | ||
| Issuance (Repayment) of Debt Securities | -1.65M | ||
| Net Cash Flow from Investing | 35.04K | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 67.74K | ||
| Net Cash Flow from Operations | 1.85M | ||
| Share Based Compensation | 64.90K | ||